ProjectHeparegenix – Synthese und Charakterisierung niedermolekularer Inhibitoren der Proteinkinase MKK4

Basic data

Acronym:
Heparegenix
Title:
Synthese und Charakterisierung niedermolekularer Inhibitoren der Proteinkinase MKK4
Duration:
01/01/2020 to 31/12/2021
Abstract / short description:
siehe Vorläuferprojekt, hier handelt es sich nur um eine Verlängerung

Involved staff

Managers

Faculty of Science
University of Tübingen
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Baden-Württemberg Center for Brazil and Latin America
Branch offices and other central facilities
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions

Local organizational units

Pharmaceutical Institute
Department of Pharmacy and Biochemistry
Faculty of Science

Funders

Ulm, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.